Items Tagged ‘OlympiAD’

January 15, 2018

Lynparza Slows Spread of Inherited Breast Cancer Caused by BRCA Mutations: First Drug Approved for BRCA Breast Cancer


CancerConnect News: The US Food and Drug Administration (FDA) has extended the approval of Lynparza (olaparib) to include the treatment of metastatic breast cancer in patients who carry the specific inherited BRCA mutation.  These patients can be identified by using the FDA-approved genetic test, BRACAnalysis CDx (Myriad Genetic Laboratories). About BRCA Breast Cancer Breast cancer […]

View full entry

Tags: brca, Breast Cancer, clinical trial, lynparza, News, olaparib, OlympiAD, PARP Inhibitors